Who Owns Terumo Company?

Terumo Corporation's journey began on September 17, 1921, as the Red Line Thermometer Corporation. It was established by a collective of Japanese medical scientists, with Dr. Kitasato Shibasaburō being a key figure. Their initial goal was to create domestically produced, high-quality medical thermometers for Japan.

Founding Vision

The founders aimed to address a critical need for reliable medical thermometers within Japan. This focus on domestic production underscored a commitment to national healthcare advancement.

Inaugural Product

The company's first product, the 'Jintan Taionkei,' was the first Japanese-made thermometer available for purchase. It quickly gained market acceptance and recognition for its quality.

Name Evolution

In 1936, the company was renamed Jintan Thermometer Corporation, a change reflecting the success of its flagship thermometer. A further rebranding occurred in October 1974, when it officially became Terumo Corporation.

Early Ownership Structure

Specific details regarding the initial equity distribution among the founding scientists are not publicly documented. Information on early angel investors or family stakes is also not readily available.

Founding Principles

The company's inception was driven by a shared medical and scientific vision. The founding team's dedication to quality and societal contribution through healthcare was a core tenet from its beginning.

Market Entry

The initial product development and market penetration were guided by the founders' commitment to excellence. This foundational approach set the stage for the company's future growth in the healthcare sector.

The establishment of Terumo Corporation was rooted in a collective scientific endeavor to meet Japan's need for reliable medical instruments. While the precise initial ownership percentages and the involvement of early investors remain private, the company's foundation was built on a shared commitment to advancing healthcare through domestic innovation. This ethos has continued to shape its trajectory, influencing its product development and market presence. Understanding the Revenue Streams & Business Model of Terumo provides further insight into its operational framework.

Key Takeaways on Founding

Terumo's origins lie in addressing a national healthcare requirement. The company's early success was driven by its commitment to quality and innovation.

• Founded as Red Line Thermometer Corporation on September 17, 1921.
• Led by prominent medical scientists, including Dr. Kitasato Shibasaburō.
• First product: 'Jintan Taionkei,' Japan's first commercially available thermometer.
• Name changed to Jintan Thermometer Corporation in 1936 and Terumo Corporation in 1974.
• Early ownership details are not publicly disclosed.
• Founding principles emphasized quality and societal contribution through healthcare.

Terumo SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Terumo Corporation's journey to its current ownership structure began with its public listing on the Tokyo Stock Exchange in 1948. The company's transition to the 1st Section of the exchange in May 1985 marked a significant milestone in its public trading history, solidifying its position as a publicly traded entity.

As of 2023, Terumo Corporation boasts a market capitalization of approximately JPY 1.98 trillion, which translates to roughly $15 billion. This substantial valuation reflects the company's significant presence in the global market. The ownership of Terumo Corporation is notably diverse, with a considerable portion held by institutional investors. These entities play a crucial role in the company's financial stability and market liquidity, often influencing corporate governance and strategic direction through their substantial shareholdings.

Key Institutional Shareholders

Major institutional investors hold significant stakes in Terumo Corporation, influencing its corporate governance and strategic decisions.

• BlackRock, Inc. holds approximately 6.1% to 6.5% of shares.
• The Vanguard Group, Inc. owns around 5.3% to 6.9% of shares.
• JPMorgan Chase & Co. holds approximately 4.4% of shares.
• Japan Trustee Services Bank, Ltd. holds about 4.7% of shares.
• Other substantial investors include Goldman Sachs Group, Inc. and Nomura Asset Management Co., Ltd.

Institutional investors like BlackRock, Inc. and The Vanguard Group, Inc. are among the largest shareholders, with BlackRock's influence extending to corporate governance, particularly concerning environmental, social, and governance (ESG) standards. These large holdings mean that these entities have a considerable voice in shareholder meetings, impacting decisions on financial reporting transparency, dividend policies, and the adoption of sustainable practices. Understanding the Target Market of Terumo also sheds light on the broad investor base that supports its operations. The collective influence of these major shareholders underscores the importance of institutional investment in shaping the company's trajectory and its commitment to responsible business practices.

Terumo PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Terumo Corporation's governance is overseen by a Board of Directors, structured to align with Japan's Companies Act, featuring an Audit and Supervisory Committee. This framework is designed to bolster corporate governance and enhance long-term value for Terumo shareholders.

The Audit and Supervisory Committee members are integral to the Board, holding voting rights and contributing to decision-making processes. A significant aspect of this committee's composition is the majority representation of independent directors. This ensures a balanced perspective, promoting transparency and objectivity in the company's operations. Terumo actively encourages shareholder engagement, offering an electronic voting platform for both individual and institutional investors to conveniently exercise their voting rights. To further support its global investor base, the company provides English translations of meeting notices, ensuring equitable access to crucial information. Terumo's corporate governance guidelines, updated as of April 1, 2025, underscore a commitment to prompt decision-making, transparency, and impartiality in management, cultivating a culture of accountability and open communication. This structure is key to understanding Terumo ownership and how decisions are made by Terumo management.

Enhancing Shareholder Value

Terumo Corporation prioritizes robust corporate governance to maximize shareholder value. The company's structure facilitates informed decision-making and accountability.

• Independent directors form a majority on the Audit and Supervisory Committee.
• An electronic voting platform is available for all shareholders.
• English translations of meeting notices are provided for international investors.
• Corporate governance guidelines emphasize transparency and timely decisions.
• Understanding the Growth Strategy of Terumo can offer insights into future value creation.

Terumo Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent strategic financial maneuvers and leadership transitions have marked Terumo Corporation's ownership landscape over the past three to five years. These changes aim to bolster shareholder value and adapt to evolving market dynamics, reflecting a proactive approach to corporate governance and capital management.

Terumo Corporation's recent financial performance underscores its strong market position, with sales revenue exceeding JPY 1 trillion for the first time in fiscal year 2024, a 12% increase from the prior year. This growth, coupled with record operating profit for the fourth consecutive year and record net income and free cash flow, reflects the positive impact of industry trends such as an aging population and increased healthcare spending in Japan, which is projected to grow at 4% annually. The company's guidance for fiscal year 2025 anticipates continued global expansion, indicating sustained investor confidence and a robust outlook for Terumo ownership trends.

Shareholder Value Enhancement

Terumo's share buyback program and stock split are designed to directly benefit shareholders. These actions aim to improve capital efficiency and potentially increase the per-share value of the company's stock.

Leadership Evolution

The recent leadership changes, including the appointment of a new President and CEO, signal a strategic shift. This transition is crucial for guiding the company's future direction and maintaining strong corporate governance.

Industry Tailwinds

The growing healthcare sector in Japan, driven by demographic shifts, provides a favorable environment for Terumo. This trend is attracting investor interest in Japanese equities, positively impacting Terumo's ownership profile.

Financial Strength and Outlook

Record financial results in FY2024, including sales surpassing JPY 1 trillion, highlight Terumo's operational success. The company's positive guidance for FY2025 suggests continued growth, which is attractive to current and potential Terumo shareholders.

Terumo Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔